GENE ONLINE|News &
Opinion
Blog

CDMO
Asia-Pacific
Japan’s Kyowa Inks Deal with Taiwan’s CDMO Firm to Manufacture Generic Drugs
2021-08-06
M&A
Philip Morris International Makes Second Acquisition in a Week to Push its “Beyond Nicotine” Strategy
2021-07-11
M&A
Medical Device Manufacturing Giant Danaher Pockets Flourishing CDMO in $9.6B Buy
2021-06-20
Manufacturing mRNA Vaccine
Samsung Biologics to Produce mRNA Vaccine Ingredients in Songdo Facility
2021-06-01
COVID-19 mRNA Vaccine
COVID-19: Moderna Enters Manufacturing Agreement with Samsung Biologics after Vaccine Bags Conditional Nod in South Korea
2021-05-23
Asia-Pacific
WuXi Biologics and WuXi STA Establish Joint Venture to Advance Bioconjugates
2021-05-17
CDMO
WuXi Biologics Completes Three Acquisition Deals to Meet Global Biologics Demands
2021-05-08
CDMO
Piramal Pharma Targets Peptide APIs Market, Acquires 100% Stake in India’s API Manufacturer Hemmo
2021-04-06
Gene Therapy
Korea’s SK Group Acquires 70% Equity in French Gene Therapy CDMO
2021-04-02
CDMO
Fujifilm Plans a Cell Culture CDMO Site in North Carolina, Creating 700+ Job Opportunities
2021-03-22
M&A Gene Therapy
Charles River Labs Expands Manufacturing Capabilities Through CDMO Acquisition
2021-02-23
Manufacturing Antibody Therapy
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Weekly Asia Highlights- South Korea and Australia
2020-08-13
1 2 3
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top